At the American Pain Society’s 31st Annual Scientific Meeting, Jon Levine, MD, PhD discussed recent data showing that kappa-opioids, generally observed to be less effective in providing pain relief than mu-receptor opioids, were not only equally effective in producing pain relief in a female patient population, but were also associated with a reduced incidence of adverse effects and greater overall patient satisfaction.
Pregabalin is an effective treatment for patients who experience below-level neuropathic pain following a spinal cord injury, according to data presented at the American Pain Society’s 31st Annual Scientific Meeting.
Intravenous (IV) prochlorperazine is more effective for the acute treatment of refractory migraine in pediatric patients than IV metoclopramide or valproate sodium. Shannon Cherney, MSN, CNP, from the Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, and colleagues sought to evaluate the efficacy of various IV pharmacotherapy options for primary intractable headache in children. The results were presented today at the American Pain Society’s 31st Annual Scientific Meeting.
Severity of sleep disturbance in patients with painful diabetic peripheral neuropathy (DPN) or post-herpetic neuralgia (PHN) may be predictive of patient response to pregabalin treatment for neuropathic pain reduction, a presentation at the American Pain Society’s 31st Annual Scientific Meeting has found.
Acetaminophen 1,000mg does provide an incremental benefit vs. acetaminophen 650mg, reported Daniel Qi, from McNeil Consumer Healthcare, Fort Washington, PA, at the American Pain Society’s 31st Annual Scientific Meeting.
Patients with chronic, noncancer-related pain who received fentanyl buccal tablet had consistent short-term efficacy across clinically meaningful analgesia measures, according to results of a study presented at the American Pain Society’s 31st Annual Scientific Meeting.
Tapentadol extended-release (ER) is a safe and effective option for the management of moderate to severe neuropathic pain associated with diabetic peripheral neuropathy (DPN), investigators reported at the American Pain Society’s 31st Annual Scientific meeting.
A multiday, flexible dosing regimen of etoricoxib demonstrated greater improvements in worst recall pain, as well as reduced usage of study and rescue medication, compared with other standard therapies. Study investigators reported at the American Pain Society’s 31st Annual Scientific Meeting that the efficacy of etoricoxib was evaluated in a third-molar dental extraction study.
Fentanyl sublingual spray can be safely titrated to an effective dose in patients with breakthrough cancer pain, a study presented at the American Pain Society’s 31st Annual Scientific Meeting has found.
Onset of postherpetic neuralgia (PHN) pain relief with a once-daily gastroretentive formulation of gabapentin can be observed as early as the second day of dosing, reported Mark Jensen, PhD, from University of Washington School of Medicine, Seattle, WA, and colleagues at the American Pain Society’s 31st Annual Scientific Meeting.
Please login or register first to view this content.
